Results 161 to 170 of about 61,572,570 (215)

Banque de France 2009 Annual Report [PDF]

, 2010
Banque de France/Central Bank of France
core  

Characteristics and outcomes of patients with LAM receiving sirolimus in France based on real-life data. [PDF]

Front Med (Lausanne)
Cottin V, Cases A, Bourdin V, Reynaud-Gaubert M, Hirschi S, Kerjouan M, Diesler R, Chardès B, Fiévez S, Assi N, Schmidt A, Denis H, Wémeau-Stervinou L, Uzunhan Y.   +13 more
europepmc   +1 more source

Obstacles and solutions for implementing amyloid-targeting treatments in Europe. [PDF]

Alzheimers Dement (Amst)
Hofmann A, Perneczky R.
europepmc   +1 more source

Long-term effect of discontinuing anticholinesterase treatment on cognitive decline and mortality in Alzheimer's disease in France: a quasi-experiment and target trial emulation study. [PDF]

Lancet Reg Health Eur
Lecerf S, Guinebretiere O, Bentegeac R, Gauthier V, Aymes E, Mekkaoui C, Dumurgier J, Amouyel P, Durrleman S, Nedelec T, Lebouvier T.   +10 more
europepmc   +1 more source

Defining Alzheimer's disease: stipulations and the ethics of diagnostic change. [PDF]

J Neurol Neurosurg Psychiatry
Michalon R, Planche V, Lemoine M, Keuck L, Villain N.   +4 more
europepmc   +1 more source

The Proceedings against the Banque de France in New York

, 2013
openaire   +1 more source

Patient Preferences for In-Person vs Remote Care for Long-Term Conditions.

JAMA Netw Open
Lenfant T, Perrodeau E, Ravaud P, Tran VT.   +3 more
europepmc   +1 more source

La formation d'une banque centrale : la Banque de France (années 1830 - années 1850)

Revue Economique, 1999
Résumé
Yves Leclercq, Leclercq, Yves
exaly   +5 more sources

Some of the next articles are maybe not open access.

Related searches:

4. The Banque de France and the Politics of Facility

2020
exaly   +2 more sources